Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XG005 in Painful Knee Osteoarthritis
CTR20222406Phase 2Completed
- Sponsor
- Zhejiang Changyu Pharmaceutical
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of naproxen etemesil in knee osteoarthritis (OA), sponsored by Zhejiang Changyu Pharmaceutical. Started Sep 2022; status: completed.
02
Drugs
naproxen etemesil
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20222406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20222406.